What is a Multiple Sclerosis Pseudo-exacerbation?
Click the video box to watch this very well presented program Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
Understanding more about MS relapse, MRI’s and Biomarkers for Multiple Sclerosis
Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
Stuart Schlossman
MS Relapse: 6 Things to Do During a Flare-Up
Multiple sclerosis (MS) can be unpredictable. About 85 percent of people with MS are diagnosed with relapsing-remitting MS (RRMS), which is characterized…
Stuart Schlossman
New Data for Genentech’s Ocrevus (ocrelizumab) Reinforce Significant Benefit on Slowing Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis
April 16, 2021 01:00 ET | Source: F. Hoffmann-La Roche Ltd 85% of treatment-naïve, early-stage relapsing-remitting multiple sclerosis (RRMS) patients achieved no…
Stuart Schlossman
Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis
Published: 18 November 2020 Click HERE to Subscribe for the MS Beacon Newsletter Abstract Spinal cord involvement is a hallmark…
Stuart Schlossman
Living with MS: African-American Perspectives – National MS Society
Click HERE to Subscribe for the MS Beacon Newsletter Living with MS: African-American Perspectives Visit our MS Learning Channel on…
Stuart Schlossman
The Gut Microbiota and Risk of Relapse in MS
If you think you have been exposed to COVID‑19 and develop a fever and symptoms, such as cough or difficulty…
Stuart Schlossman
How to Recognize an MS Attack
Most forms of multiple sclerosis (MS) involve stretches of time when you feel good and other times when your symptoms…
Stuart Schlossman
Treatment for MS #Flare-Ups (#Exacerbations)
If you have MS and you think you’re having a flare-up, call your MS doctor or nurse as soon as…
Stuart Schlossman
Stress-full life events and multiple sclerosis: A population-based incident case-control study.
Mult Scler Relat Disord. 2018 Sep 22;26:168-172. doi: 10.1016/j.msard.2018.09.026. [Epub ahead of print] Abdollahpour I1, Nedjat S2, Mansournia MA3, Eckert S4, Weinstock-Guttman B5. Author information…
Stuart Schlossman
